Gary Hennerberg
Directeur/Membre du Conseil chez FINDIT
Fortune : 739 625 $ au 30/04/2024
Postes actifs de Gary Hennerberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FINDIT | Directeur/Membre du Conseil | 08/03/2024 | - |
| Secrétaire Général | 08/03/2024 | - |
Historique de carrière de Gary Hennerberg
Anciens postes connus de Gary Hennerberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Directeur/Membre du Conseil | 01/05/2016 | - |
| Sales & Marketing | 01/05/2016 | - |
Formation de Gary Hennerberg
| Fort Hays State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Sales & Marketing | 1 |
| Corporate Secretary | 1 |
Sectorielle
| Health Technology | 2 |
| Technology Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FINDIT | Technology Services |
| Entreprise privées | 1 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
- Bourse
- Insiders
- Gary Hennerberg
- Expérience